Shenzhen Kangtai Biological Products Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 69.4 | -100% | 67.66 | -100% |
| P/S |
|
10.03 | 6.51 | 54.14% |
|
|
| P/BV |
|
3.07 | 3.96 | -22.4% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
-94.89 | 11.85 | -900.86% |
|
|
| Ev/S |
|
9.65 | 5.98 | 61.56% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
-0.0072 | 0.0396 | -118.18% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
3.53 | 16.34 | -78.4% | 31.33 | -88.73% |
| ROE |
|
-2.1 | 11.95 | -117.58% |
|
|
| ROA |
|
0.47 | 5.4 | -91.3% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
-6.63 | 16.23 | -140.84% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
9.27 | 14.63 | -36.65% | 6.48 | +42.93% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
-11.7 | 3.6 | -425.09% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 1.83 | -100% | 0.5461 | -100% |
| Number of years of dividend growth |
|
0 | 1.44 | -100% | ||
| DSI |
|
0.9286 | 0.9113 | 1.89% |
|
|
| Average dividend growth |
|
4.39 | 10.4 | -57.75% |
|
|
| Average percentage for 5 years |
|
0.5461 | 1.14 | -52.18% |
|
|
| Average percentage for payments |
|
23.13 | 44.8 | -48.37% |
|
|
| Difference from average difference in sector |
|
-1.83 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
8/10
|
78.94 | 61.43 | 28.5% | ||
| Growth impulse Ebitda in 5 years |
|
-104.96 | 158.62 | -166.17% | ||
| Growth impulse Net Income in 5 years |
|
49.92 | 66.93 | -25.41% | ||
| Growth impulse FCF in 5 years |
|
164.25 | 248.41 | -33.88% | ||
| Growth impulse EPS in 5 years |
|
10.39 | 73.29 | -85.82% |
IP Score
4.2/10
